GlassScriptPhysician profile
Marvin Craig
NPI 1912947151
$1,649.32
in general payments reported to CMS, 2019-2025
17 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $92.57 · 2021: $183 · 2022: $127 · 2023: $32.90 · 2024: $84.13 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.46 |
| Education | $128.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $719.71 | 2019-2025 | |
| Abbvie INC. | $239.47 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $95.90 | 2022-2025 | Aptima, Coolseal Generator |
| Aspira Women'S Health INC | $85.42 | 2019 | |
| Astellas Pharma US INC | $74.55 | 2019-2025 | Veozah |
| Myovant Sciences INC. | $70.15 | 2021-2022 | |
| Agile Therapeutics, INC. | $56.76 | 2021-2022 | |
| Pinnacle, INC | $51.71 | 2024 | |
| Sage Therapeutics, LLC | $46.29 | 2025 | Zurzuvae |
| Allergan, INC. | $45.71 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $44.83 | 2024-2025 | Myfembree |
| Lilly USA, LLC | $33.94 | 2025 | Mounjaro, Zepbound |
| Pfizer INC. | $29.58 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.19 | 2022 | |
| Exeltis, USA INC. | $14.16 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $13.76 | 2022 | |
| Amgen INC. | $13.19 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.